An observational study in Hyperextension Spasms and Involuntary Movements, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2025-12-05.
Sponsored by Centre Hospitalier Universitaire de Nīmes · Observational
This study compares two modes of the NETTI wheelchair (dynamic or sitting) for patients with hyperkinetic syndromes, to discover which mode is the most comfortable and best suited to these patients.
It is a prospective, single-center pilot study comparing two medical devices evaluated using SCED (Single Case Experimental Design) ABAB methodology: NETTI DYNAMIC chair in dynamic mode (intervention group; phase B) versus the same chair in static mode (control group; phase A). The subject will be his/her own control
Hyperkinetic syndromes are characterized by excessive or involuntary movements throughout the day. These abnormal movements interfere with maintaining the ideal sitting position and cause positioning disorders that may have functional repercussions. To facilitate staying in the ideal position, therapists adapt sitting positions. Together with the patient, they choose the position that appears to be the most functional and comfortable. To maintain this position, the solutions proposed are mainly based on restraint (shells, abduction blocks, straps, etc.). These can be poorly tolerated by the patient, causing discomfort or even pain which can hinder participation. Repeated stresses on the supports, and on the chair itself, leads to frequent breakage. Also, depending on the underlying neurological mechanisms behind the abnormal movements, the question arises as to whether restraint increases the frequency or amplitude of abnormal movements by generating oppositional constraints, areas of discomfort and/or pain, or by reducing functional capacities and frustration caused by these abnormal movements (Cimolin et al. 2009). All these issues can have a significant impact on the quality of life of this population of patients suffering from abnormal movements and who are almost exclusively in wheelchairs. To address these issues, dynamic wheelchair systems have been have been developed to absorb the mechanical stresses generated by abnormal movements.
The chair's dynamic components absorb the force. When the patient's force ceases, the stored energy is returned by the dynamic component which, in turn, helps the patient return to his or her starting position. The ideal seating system enables controlled movement whilst providing mechanical stability.
This is a prospective, single-center pilot study comparing the two medical device modes using an ABAB-type Single Case Experimental Design methodology: The NETTI DYNAMIC chair in dynamic mode (interventional group; phase B) versus the same chair in static mode (control group; phase A). The subject will be his/her own control.
Phase B (intervention) will be performed by positioning the subject on the Netti Dynamic chair in its dynamic configuration. Phase A (control), on the other hand, will be performed positioned on the same chair, but in static mode (backrest and seat locked by means of a jack and pin, legrest and headrest replaced by standard elements and headrest replaced by standard components, making it impossible to adapt the chair's of the chair). In this way, the specific effect of the dynamic mode will be able to be controlled.
The ABAB study design was chosen for this study because it provides the highest level of evidence evidence (Level 1; OCEBM Levels of Evidence Working Group. (2011). "The Oxford 2011 Levels of Evidence." Oxford Centre for Evidence-Based Medicine). It is characterized by the presence of two phases (phase A: control phase and phase B: intervention phase) which are alternated twice.
Each phase must comprise three to five measures to enable reliable statistical analysis. This approach is particularly appropriate for evaluating medical devices, especially when the when the population concerned is heterogeneous. Indeed, an intensive, prospective study of a few individuals, using a methodology defined a priori, including systematic observations, repeated measurements and appropriate data analysis is the most appropriate in this case.
270 studies on the registry are indexed under Dyskinesias; 41 are open to participants now.
This study's enrollment of 4 is below the median of 70 across 70 observational studies indexed under Dyskinesias.
Browse Dyskinesias studies →Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 587 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population is made up of patients with involuntary extension movements at a frequency of more than 3/hour, requiring at least one wheelchair repositioning every 2 hours, cared for in a medico-educational institute, a specialized residence such as a Specialised Care Home or a Medicalized Care Home, or living at home if necessary.
Exclusion Criteria:
The patient will be positioned on the Netti Dynamic chair in static mode.
Device: Observation
The patient will be positioned on the Netti Dynamic chair in dynamic mode.
Device: Observation
Patients will be filmed in sitting position in the NETTI DYNAMIC chair, either in static mode or dynamic mode for a period of 3 hours each time.
Forward slippage in static mode (PHASE A)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 7
Forward slippage in static mode (PHASE A)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 14
Forward slippage in static mode (PHASE A)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 21
Forward slippage in static mode (PHASE A)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 28
Forward slippage in dynamic mode (PHASE B)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 7
Forward slippage in dynamic mode (PHASE B)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 14
Forward slippage in dynamic mode (PHASE B)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 21
Forward slippage in dynamic mode (PHASE B)
Measurement of forward slippage (mm) of the pelvis in relation to the backrest of the chair. This assessment will be made after each involuntary movement over the 3-hour observation period.Collection tools/methods : Go pro positioning: see face + torso Sensor positioning: 4 motion sensors record continuously throughout the sequence: one on the back of the chair, one on the thorax over the sternum, one on the anterior superior iliac spine and one on the top of the homolateral thigh. Motion sensor data are sent by e-mail ( .csv file), together with a timeline (word file) of the occurrence of abnormal movements. They are sent pseudonymized simultaneously to Mike Dongelmans (ALU REHAB AS, Norway) and MotionCatch / Denmark (which carries out the analysis on behalf of ALU REHAB AS). In order to mark the "involuntary movement" events on the video, the collaborator will have to be able to identify which chair it is, but then, for the forward-slippage data analysis, this will be done under
Time frame: End of the 3-hour period on Day 28
Peak force in static mode (PHASE A)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 7
Peak force in static mode (PHASE A)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 14
Peak force in static mode (PHASE A)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 21
Peak force in static mode (PHASE A)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 28
Peak force in dynamic mode (PHASE B)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 7
Peak force in dynamic mode (PHASE B)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 14
Peak force in dynamic mode (PHASE B)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 21
Peak force in dynamic mode (PHASE B)
Measurement of the peak force (F max ) exerted on the user's back during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 28
Maximum downward force in static mode (PHASE A)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 7
Maximum downward force in static mode (PHASE A)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 14
Maximum downward force in static mode (PHASE A)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 21
Maximum downward force in static mode (PHASE A)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 28
Maximum downward force in dynamic mode (PHASE B)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 7
Maximum downward force in dynamic mode (PHASE B)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 14
Maximum downward force in dynamic mode (PHASE B)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 21
Maximum downward force in dynamic mode (PHASE B)
Measurement of the maximum downward force (Newton) exerted on the user's seat during an involuntary movement. This assessment will be made after each involuntary movement over the 3-hour observation period.
Time frame: After each involuntary movement over the 3-hour observation period on Day 28
Patient's comfort in static mode (PHASE A)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 7
Patient's comfort in static mode (PHASE A)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 14
Patient's comfort in static mode (PHASE A)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 21
Patient's comfort in static mode (PHASE A)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 28
Patient's comfort in dynamic mode (PHASE B)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 7
Patient's comfort in dynamic mode (PHASE B)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 14
Patient's comfort in dynamic mode (PHASE B)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 21
Patient's comfort in dynamic mode (PHASE B)
Self-assessment of the comfort felt by the patient when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 28
Caregiver's comfort in static mode (PHASE A)
Hetero-assessment of the comfort felt by the patient's caregiver when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 7
Caregiver's comfort in dynamic mode (PHASE B)
Hetero-assessment of the comfort felt by the patient's caregiver when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 14
Caregiver's comfort in dynamic mode (PHASE B)
Hetero-assessment of the comfort felt by the patient's caregiver when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 21
Caregiver's comfort in dynamic mode (PHASE B)
Hetero-assessment of the comfort felt by the patient's caregiver when using the chair (Visual Analog Scale between 0 and 100mm) at the end of each measurement phase.
Time frame: At the end of the 3-hour observation period on Day 28
Number of repositionings required in static mode (PHASE A)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 7
Number of repositionings required in static mode (PHASE A)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 14
Number of repositionings required in static mode (PHASE A)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 21
Number of repositionings required in static mode (PHASE A)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 28
Number of repositionings required in dynamic mode (PHASE B)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 7
Number of repositionings required in dynamic mode (PHASE B)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 14
Number of repositionings required in dynamic mode (PHASE B)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 21
Number of repositionings required in dynamic mode (PHASE B)
Number of repositionings required during the test phase.
Time frame: At the end of the 3-hour observation period on Day 28
Discomfort perceived by the caregiver in static mode (PHASE A)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 7
Discomfort perceived by the caregiver in static mode (PHASE A)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 14
Discomfort perceived by the caregiver in static mode (PHASE A)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 21
Discomfort perceived by the caregiver in static mode (PHASE A)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 28
Discomfort perceived by the caregiver in dynamic mode (PHASE B)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 7
Discomfort perceived by the caregiver in dynamic mode (PHASE B)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 14
Discomfort perceived by the caregiver in dynamic mode (PHASE B)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 21
Discomfort perceived by the caregiver in dynamic mode (PHASE B)
Caregiver's self-assessment of the discomfort felt over the observation period using a Visual Analog Scale scale from 0 to 100mm.
Time frame: At the end of the 3-hour observation period on Day 28
Safety as perceived by the caregiver/carer in static mode (PHASE A)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 7
Safety as perceived by the caregiver/carer in static mode (PHASE A)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 14
Safety as perceived by the caregiver/carer in static mode (PHASE A)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 21
Safety as perceived by the caregiver/carer in static mode (PHASE A)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 28
Safety as perceived by the caregiver/carer in dynamic mode (PHASE B)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 7
Safety as perceived by the caregiver/carer in dynamic mode (PHASE B)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 14
Safety as perceived by the caregiver/carer in dynamic mode (PHASE B)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 21
Safety as perceived by the caregiver/carer in dynamic mode (PHASE B)
Hetero-evaluation by Visual Analog Scale scale (0-100mm) of the safety felt by the caregiver/carer when using the chair during the observation phase.
Time frame: At the end of the 3-hour observation period on Day 28
Average of peak forces exerted on the wheelchair's backrest in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 7
Average of peak forces exerted on the wheelchair's backrest in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 14
Average of peak forces exerted on the wheelchair's backrest in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 21
Average of peak forces exerted on the wheelchair's backrest in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 28
Average of peak forces exerted on the wheelchair's backrest in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 7
Average of peak forces exerted on the wheelchair's backrest in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 14
Average of peak forces exerted on the wheelchair's backrest in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 21
Average of peak forces exerted on the wheelchair's backrest in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the rear support of the wheelchair.
Time frame: At the end of the 3-hour observation period on Day 28
Average of peak forces exerted on the wheelchair's seat in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 7
Average of peak forces exerted on the wheelchair's seat in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 14
Average of peak forces exerted on the wheelchair's seat in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 21
Average of peak forces exerted on the wheelchair's seat in static mode (PHASE A)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 28
Average of peak forces exerted on the wheelchair's seat in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 7
Average of peak forces exerted on the wheelchair's seat in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 14
Average of peak forces exerted on the wheelchair's seat in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 21
Average of peak forces exerted on the wheelchair's seat in dynamic mode (PHASE B)
Calculation of the average of the peak forces (Fmax) exerted on the seat of the wheelchair measured for all involuntary movements.
Time frame: At the end of the 3-hour observation period on Day 28
Sex
The sex of each patient will be recorded as MALE/FEMALE/NON-BINARY
Time frame: Day 0
Age
The age of each patient will be recorded in YEARS
Time frame: Day 0
Height
The height of each patient will be recorded in centimeters
Time frame: Day 0
Weight
The weight of each patient will be recorded in kilograms
Time frame: Day 0
Body mass index
The patient's body mass index (= kg/m2 ) will be calculated via a computerized procedure.
Time frame: Day 0
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Nīmes